Another day, another House committee approval of a bill to legalize marijuana in Minnesota.
Articles
Digital Therapeutics: Optimizing Psychedelics Therapies With Next-Generation IP
Digital therapeutics is the wave of the future in healthcare. The psychedelic drug industry is at the forefront for this new tech.
Biden’s Already On Board With Federal Marijuana Legalization Even If He Doesn’t Use That Word, Booker Says
Sen. Cory Booker says that President Joe Biden is already where he needs to be to get a bill to end federal marijuana prohibition enacted into law—even if he personally opposes legalization. Confusion about the president’s position comes down to semantics, the senator indicated.
Novamind Increases Strategic Investment in Bionomics
Novamind increases its strategic investment in Bionomics Limited, in support of its plans for a Phase IIb clinical trial for PTSD.
New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
A New England Journal of Medicine study found CMPS's COMP360 psilocybin therapy performed better than the leading antidepressant.
Psychedelic Drugs: The Cure For ‘COVID Isolation Syndrome’?
A recent study shows HALF of all adults already experiencing anxiety due to the social isolation from COVID-19 lockdowns. COVID Isolation Syndrome.
MINDCURE (CSE: MCUR | OTC: MCURF) Announces The Addition Of Daniel Herrera, A Pharmaceutical Industry Executive With Specific Experience In Medical Psychoactive Segment
Mr. Herrera, Who Will Join The Company As Its Vice President Of Growth And Strategic Partnerships, Has 15+ Years Of Global Life Sciences Experience And Will Help To Drive MINDCURE’s Commercial Focus And Strategic Partnerships
California Bill To Legalize Possession Of Psychedelics Clears Second Senate Committee
A second California Senate committee has approved a bill to legalize possession of a wide range of psychedelics and create a working group to study broader reform.
Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening
Mydecine commences screening psilocybin-based drug candidates.
GH Research Announces Closing of $125 Million Oversubscribed Series B Financing
Ireland-based GH Research has just raised $125 million in an oversubscribed Series B financing round.
Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003 and CYB004 for Investigational New Drug Applications
Cybin prepares two drug candidates, CYB003 and CYB004 for Investigational New Drug applications.
Breaking News: MINDCURE (CSE: MCUR | OTC: MCURF) Announces Partnership with Speak Ai to Enhance iSTRYM, the Company’s Psychedelic Digital Therapeutics Technology Platform
Utilizing Speak Ai’s technology, iSTRYM will provide-AI-driven intelligence to help therapists identify the most efficient and efficacious outcomes for patients of psychedelic assisted psychotherapy
New Mexico Just Officially Legalized Cannabis
It’s official: the leader of New Mexico just signed a cannabis bill into law, adding to the growing ranks of already legal U.S. states.
Uber Will ‘Absolutely’ Explore Marijuana Deliveries When Federal Prohibition Ends, CEO Says
The CEO of Uber said on Monday that the ride share company will “absolutely” explore adding marijuana deliveries to its services when federal prohibition ends.
How Cannabis Became the Gateway Drug…For Psychedelic Drug Normalization
Forty years ago, cannabis was labelled "a Gateway Drug" to harder drug use -- such as psychedelics. Today, cannabis is the Gateway Drug to psychedelics legalization.